The movement disorders can be prominent and in 14% of anti-IgLON5 disease patients, initial symptoms may suggest a diagnosis of progressive supranuclear palsy (PSP) [3, 6, 7]. This evidence concerns the gene IGLON5 and supranuclear palsy, progressive, 1.